Ray Co., Ltd. (228670.KQ)

KRW 6250.0

(-2.5%)

Long Term Debt Summary of Ray Co., Ltd.

Ray Co., Ltd.'s latest annual long term debt in 2023 was 155.4 Million KRW , down -99.52% from previous year.
Ray Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 22.31 Billion KRW , up 85.93% from previous quarter.
Ray Co., Ltd. reported annual long term debt of 32.6 Billion KRW in 2022, down -25.99% from previous year.
Ray Co., Ltd. reported annual long term debt of 44.05 Billion KRW in 2021, up 4769.97% from previous year.
Ray Co., Ltd. reported quarterly long term debt of 12 Billion KRW for 2024 Q1, up 7624.77% from previous quarter.
Ray Co., Ltd. reported quarterly long term debt of 15.92 Billion KRW for 2023 Q3, down -0.07% from previous quarter.

Annual Long Term Debt Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Long Term Debt of Ray Co., Ltd. (2023 - 2017)

Year	Long Term Debt	Long Term Debt Growth
2023	155.4 Million KRW	-99.52%
2022	32.6 Billion KRW	-25.99%
2021	44.05 Billion KRW	4769.97%
2020	904.65 Million KRW	-57.59%
2019	2.13 Billion KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	22.31 Billion KRW	85.93%
2024 Q1	12 Billion KRW	7624.77%
2023 Q3	15.92 Billion KRW	-0.07%
2023 Q4	155.4 Million KRW	-99.02%
2023 FY	155.4 Million KRW	-99.52%
2023 Q2	15.93 Billion KRW	-51.13%
2023 Q1	32.6 Billion KRW	0.0%
2022 Q3	62.31 Billion KRW	39.25%
2022 Q4	32.6 Billion KRW	-47.67%
2022 Q2	44.75 Billion KRW	0.8%
2022 Q1	44.39 Billion KRW	0.77%
2021 Q4	44.05 Billion KRW	49.43%
2021 Q3	29.48 Billion KRW	0.0%

Peer Long Term Debt Comparison of Ray Co., Ltd.

Name	Long Term Debt	Long Term Debt Difference
Osang Healthcare Co.,Ltd	367.49 Million KRW	57.713%
InBody Co.,Ltd	3.63 Billion KRW	95.726%
Curexo Inc.	1.48 Billion KRW	89.557%
Seegene, Inc.	1.42 Billion KRW	89.083%
i-SENS, Inc.	45.74 Billion KRW	99.66%
Gencurix Inc.	5.47 Billion KRW	97.162%
Sugentech Inc.	240 Million KRW	35.25%
L&C Bio Co., Ltd	541.32 Million KRW	71.292%